Dr. Sulaiman Al Habib Medical Services stock costs SAR 226.30 at 32.75 times earnings
Published on 10/13/2026 at 13:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS- Dr. Sulaiman Al Habib Medical Services stock was valued at SAR 226.30 on October 13, 2026, with a 32.75 times earnings multiple.
- Market capitalization stood at SAR 79.2 billion, while the 52-week high was SAR 281.20.
- The stock was 19.52 percent below its 52-week high and up 0.35 percent versus the SAR 225.50 prior close.
- The price-to-earnings ratio exceeded Dallah Healthcare's 17.65 and Almoosa Health's 25.75 on October 13, 2026.
Dr. Sulaiman Al Habib Medical Services (ISIN SA1510P1UMH1) was trading at SAR 226.30 on October 13, 2026, at 2:27 p.m. AST, up 0.35 percent versus the SAR 225.50 prior close. The stock is listed on Tadawul under ticker 4013.SR and the stated ISIN, according to Global Banking and Finance.
Price remains below yearly high
The quote stood SAR 54.90 below the 52-week high of SAR 281.20, leaving the stock 19.52 percent below that level. Its 52-week low was SAR 210.10, putting the latest price SAR 16.20 above the bottom of the range and 7.71 percent higher than the low.
Trading volume reached 74,670 shares by the quoted time, compared with an average volume of 138,109 shares. That is 45.93 percent below the average, making turnover a quieter part of the session than the price change.
Valuation and market scale
Dr. Sulaiman Al Habib Medical Services carried a market capitalization of SAR 79.2 billion on October 13, 2026. The price-to-earnings ratio was 32.75, placing the valuation above the multiples of the two healthcare peers used below.
The group operates hospitals, medical complexes, outpatient surgery centers, pharmacies and supporting healthcare services. Its profile also includes laboratories, home medical services, telemedicine and healthcare technology, giving the company several operating lines beyond inpatient care.
Comparison with peers
Dr. Sulaiman Al Habib Medical Services (Tadawul, SAR): plus 0.35 percent, price-to-earnings ratio 32.75, market capitalization SAR 79.2 billion
Dallah Healthcare (Tadawul, SAR): minus 0.90 percent, price-to-earnings ratio 17.65, market capitalization SAR 7.8 billion
Almoosa Health (Tadawul, SAR): plus 0.35 percent, price-to-earnings ratio 25.75, market capitalization SAR 5.0 billion
What the price position means
The comparison puts the stock's 32.75 times earnings multiple 85.55 percent above Dallah Healthcare's 17.65 and 27.18 percent above Almoosa Health's 25.75. The current valuation therefore remains the clearest market statistic distinguishing the company from these two listed healthcare names.
Current trading level
At SAR 226.30, the stock was closer to its 52-week low than its high on October 13, 2026, despite the 0.35 percent daily increase. The price was also 7.71 percent above the range low, while the market capitalization remained SAR 79.2 billion.
Dr. Sulaiman Al Habib Medical Services market snapshot
- Company: Dr. Sulaiman Al Habib Medical Services Group Company
- ISIN: SA1510P1UMH1
- Ticker: 4013.SR
- Primary exchange: Tadawul
- Price Tadawul (as of October 13, 2026, 2:27 p.m. AST): SAR 226.30
- Change versus prior close: plus 0.35 percent
- Prior close Tadawul (October 12, 2026): SAR 225.50
- Market capitalization: SAR 79.2 billion (as of October 13, 2026)
- 52-week range: SAR 210.10-281.20 (as of October 13, 2026)
- Sector / Industry: Healthcare / Medical - Care Facilities
Market context: Current market reports.
More news and analyses on Dr. Sulaiman Al Habib Medical Services stock
